Takeda Pharmaceutical Li...

OTC: TKPHF · Real-Time Price · USD
29.45
0.00 (0.00%)
At close: Aug 13, 2025, 11:10 AM

Takeda Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
108.14B 144.07B 317.04B 230.17B 376.17B
Depreciation & Amortization
761.4B 728B 664.4B 583.15B 559.67B
Stock-Based Compensation
72.87B 70.87B 60.67B 43.37B 37.66B
Other Working Capital
34.56B -145.47B 63.57B -107.7B 222.5B
Other Non-Cash Items
107.21B 120.81B -97.74B 95.4B -228.42B
Deferred Income Tax
66.94B -91.41B 58.05B 72.41B -9.94B
Change in Working Capital
-59.37B -256B -25.26B 98.61B 275.78B
Operating Cash Flow
1,057.2B 716.34B 977.16B 1,123.1B 1,010.9B
Capital Expenditures
-379.63B -480.73B -633.69B -186.04B -236.47B
Cash Acquisitions
77.24B n/a 7.96B -21.48B 530.39B
Purchase of Investments
-111.38B -40.07B -10.15B -8.34B -12.6B
Sales Maturities Of Investments
29.44B 8.02B 22.25B 16.92B 74.6B
Other Investing Acitivies
-161.57B -256.4B 6.53B 808M 37.6B
Investing Cash Flow
-367.06B -463.86B -607.1B -198.13B 393.53B
Debt Repayment
-314.31B 1.51B -325.07B -600.48B -660.5B
Common Stock Repurchased
-51.86B -2.33B -26.93B -77.53B -2.14B
Dividend Paid
-302.5B -287.19B -279.42B -283.67B -283.36B
Other Financial Acitivies
-82.75B -66.42B -77.73B -108.59B -142.35B
Financial Cash Flow
-751.42B -354.42B -709.15B -1,070.3B -1,088.4B
Net Cash Flow
-72.69B -75.73B -316.17B -116.53B 328.61B
Free Cash Flow
677.56B 235.61B 343.47B 937.07B 774.46B